These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 8147180)

  • 1. [Postmenopausal hemorrhage and endometrial cancer in tamoxifen therapy].
    Krause A; Gerber B
    Zentralbl Gynakol; 1994; 116(1):44-7. PubMed ID: 8147180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy.
    Corley D; Rowe J; Curtis MT; Hogan WM; Noumoff JS; Livolsi VA
    Obstet Gynecol; 1992 Jan; 79(1):111-6. PubMed ID: 1727568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen.
    Lahti E; Blanco G; Kauppila A; Apaja-Sarkkinen M; Taskinen PJ; Laatikainen T
    Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):660-4. PubMed ID: 8469450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer.
    Deligdisch L; Kalir T; Cohen CJ; de Latour M; Le Bouedec G; Penault-Llorca F
    Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E; Libera H; Kimmig R; Forsting M
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen associated uterine pathology in breast cancer patients with abnormal bleeding.
    Fotiou S; Tserkezoglou A; Hadjieleftheriou G; Apostolikas N; Karydas I; Stravolemos K
    Anticancer Res; 1998; 18(1B):625-9. PubMed ID: 9584044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
    Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
    Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histological analysis of endometrial polyps in breast cancer patients treated with tamoxifen (nolvadex)].
    Ivanova V; Karaivanov M; Raĭcheva S; Marinov E; Gorchev G
    Akush Ginekol (Sofiia); 2004; 43(2):33-6. PubMed ID: 15185527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen and endometrial cancer.
    Segna RA; Dottino PR; Deligdisch L; Cohen CJ
    Mt Sinai J Med; 1992 Oct; 59(5):416-8. PubMed ID: 1435840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
    Cheng WF; Lin HH; Torng PL; Huang SC
    Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
    Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
    J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients.
    Cohen I; Bernheim J; Azaria R; Tepper R; Sharony R; Beyth Y
    Gynecol Oncol; 1999 Oct; 75(1):136-41. PubMed ID: 10502440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex)].
    Ivanova V; Karaivanov M; Marinov E; Gorchev G; Velkova A; Khristova P
    Akush Ginekol (Sofiia); 2003; 42(5):3-8. PubMed ID: 14682005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tamoxifen and endometrial pathology].
    Negoiţă M; Terinte C; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adjuvant therapy of breast cancer with tamoxifen and endometrial carcinoma].
    Mignotte H; Sasco AJ; Lasset C; Saez S; Rivoire M; Bobin JY
    Bull Cancer; 1992; 79(10):969-77. PubMed ID: 1292764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial pathologies associated with postmenopausal tamoxifen treatment.
    Cohen I
    Gynecol Oncol; 2004 Aug; 94(2):256-66. PubMed ID: 15297160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic changes in endometrial polyps associated with tamoxifen show no evidence for its action as an external carcinogen.
    Dal Cin P; Timmerman D; Van den Berghe I; Wanschura S; Kazmierczak B; Vergote I; Deprest J; Neven P; Moerman P; Bullerdiek J; Van den Berghe H
    Cancer Res; 1998 Jun; 58(11):2278-81. PubMed ID: 9622058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment.
    Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Coibion M; Bianco AR
    Hum Reprod; 2006 Feb; 21(2):545-53. PubMed ID: 16210385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iatrogenic endometrial megapolyps in women with breast carcinoma.
    Berezowsky J; Chalvardjian A; Murray D
    Obstet Gynecol; 1994 Oct; 84(4 Pt 2):727-30. PubMed ID: 9205466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.
    Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR
    AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.